title: Preclamol. A "designer drug" in the treatment of advanced Parkinson's disease.
authors.affiliation: Institute of Clinical Neurophysiology, University Medical Centre, Ljubljana, Slovenia.
authors.forename: Z
authors.initials: Z
authors.lastname: Pirtosek
authors.forename: M
authors.initials: M
authors.lastname: Merello
authors.forename: A
authors.initials: A
authors.lastname: Carlsson
authors.forename: G
authors.initials: G
authors.lastname: Stern
mesh_terms: D000978:Antiparkinson Agents / Q000627:therapeutic use*; D018491:Dopamine Agonists / Q000627:therapeutic use*; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*; D010880:Piperidines / Q000627:therapeutic use*
chemical_list: D000978:Antiparkinson Agents; D018491:Dopamine Agonists; D010880:Piperidines; C026539:preclamol